- Home
- OSUR vs NMRA Comparison
OSUR vs NMRA Comparison
Compare OSUR & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSUR
- NMRA
- Stock Information
- Founded
- OSUR 2000
- NMRA 2019
- Country
- OSUR United States
- NMRA United States
- Employees
- OSUR N/A
- NMRA N/A
- Industry
- OSUR Medical/Dental Instruments
- NMRA
- Sector
- OSUR Health Care
- NMRA
- Exchange
- OSUR Nasdaq
- NMRA Nasdaq
- Market Cap
- OSUR 229.7M
- NMRA 268.5M
- IPO Year
- OSUR 1986
- NMRA 2023
- Fundamental
- Price
- OSUR $3.22
- NMRA $1.50
- Analyst Decision
- OSUR Hold
- NMRA Hold
- Analyst Count
- OSUR 1
- NMRA 8
- Target Price
- OSUR $3.00
- NMRA $5.83
- AVG Volume (30 Days)
- OSUR 607.0K
- NMRA 372.9K
- Earning Date
- OSUR 11-05-2025
- NMRA 11-11-2025
- Dividend Yield
- OSUR N/A
- NMRA N/A
- EPS Growth
- OSUR N/A
- NMRA N/A
- EPS
- OSUR N/A
- NMRA N/A
- Revenue
- OSUR $138,533,000.00
- NMRA N/A
- Revenue This Year
- OSUR N/A
- NMRA N/A
- Revenue Next Year
- OSUR $5.35
- NMRA N/A
- P/E Ratio
- OSUR N/A
- NMRA N/A
- Revenue Growth
- OSUR N/A
- NMRA N/A
- 52 Week Low
- OSUR $2.36
- NMRA $0.61
- 52 Week High
- OSUR $4.60
- NMRA $17.19
- Technical
- Relative Strength Index (RSI)
- OSUR 52.52
- NMRA 49.58
- Support Level
- OSUR $3.25
- NMRA N/A
- Resistance Level
- OSUR $3.37
- NMRA $1.70
- Average True Range (ATR)
- OSUR 0.13
- NMRA 0.08
- MACD
- OSUR -0.00
- NMRA -0.08
- Stochastic Oscillator
- OSUR 23.81
- NMRA 81.74
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.